Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07377747 · ClinicalTrials.gov registry record
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
A clinical trial of Retroperitoneal Liposarcoma, sponsored by Australia and New Zealand Sarcoma Association.
- Recruiting
- Registry status
- 100
- Enrollment target
- 9
- Study locations
NCT07377747 is a study of Retroperitoneal Liposarcoma that is actively recruiting participants, run by Australia and New Zealand Sarcoma Association. The registered enrollment target is 100 participants. The trial reports 9 study locations across 8 states.
The verdict
NCT07377747, a study of Retroperitoneal Liposarcoma, is actively recruiting participants, sponsored by Australia and New Zealand Sarcoma Association.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 9
- Study locations
Study Summary
The aim of the study is to collect prospective data on the treatment outcomes in patients with first localized, resectable recurrent retroperitoneal well-differentiated and/or dedifferentiated liposarcoma undergoing curative intent treatment. Patients enrolled in this study will form a validation cohort of the TARPSWG recurrent RPS nomogram. The treatment decision (surgery alone, or preoperative RT +/- chemotherapy followed by surgery) is per the institutional multidisciplinary team recommendation.
Conditions Studied
Study Locations (9)
New South Wales
- Chris O'Brien Lifehouse - Camperdown
- Prince of Wales Hospital - Randwick
Georgia
- Emory Winship Cancer Institute - Atlanta
Ohio
- OSU James Hospital - Columbus
Texas
- MD Anderson Cancer Center - Houston
Victoria
- Peter MacCallum Cancer Centre - Melbourne
Flemish Brabant
- UZ Leuven - Leuven
São Paulo
- A.C.Camargo Cancer Center - Fundacao Antonio Prudente - Liberdade
North Holland
- The Netherlands Cancer Institute - Amsterdam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-09-05 |
| Est. Completion | 2032-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07377747
The ClinicalTrials.gov registry entry for NCT07377747 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Australia and New Zealand Sarcoma Association, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Retroperitoneal Liposarcoma appearing as the primary indexed condition, and to 0 interventions.
NCT07377747 reports 9 study locations spanning 8 distinct geographic areas - top geographies include New South Wales, Georgia, Ohio.
Frequently Asked Questions
What is clinical trial NCT07377747 about?
NCT07377747 is a clinical study titled "Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma". The aim of the study is to collect prospective data on the treatment outcomes in patients with first localized, resectable recurrent retroperitoneal well-differentiated and/or dedifferentiated liposarcoma undergoing curative intent treatment. Patients enrolled in this study will form a validation co...
What is the current status of trial NCT07377747?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-09-05. Estimated completion is 2032-12.
What conditions does trial NCT07377747 study?
This clinical trial studies the following conditions: Retroperitoneal Liposarcoma.
Who is sponsoring clinical trial NCT07377747?
This trial is sponsored by Australia and New Zealand Sarcoma Association, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07377747 being conducted?
This trial has 9 study locations across Georgia, Ohio, Texas, New South Wales, Victoria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retroperitoneal Liposarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.